Journal article
Potential limitations of activity tracking devices in monitoring effects of treatment for sarcoidosis
Sarcoidosis, vasculitis, and diffuse lung diseases, Vol.40(1), e2023010
03/28/2023
DOI: 10.36141/svdld.v40i1.12395
PMCID: PMC10099655
PMID: 36975058
Abstract
Introduction: activity tracker device usage can help analyze the impact of disease state and therapy on patients in clinical practice. factors such as age, race, and gender may contribute to difficulties with using such technology. Objective: we evaluated the effect of age, race, and gender on the usability of the Fitbit OneTM activity tracking device in sarcoidosis patients and the impact of device on sarcoidosis patients' activity.
Method: patients participated in a six-month prospective study where were asked to wear a Fitbit OneTM activity tracker daily. device usage education was provided at study enrollment. weekly data download and submission reports to participating centers was required. patients were asked to complete a post-study questionnaire reviewing the motivation of the activity tracker on daily activity.
Results: at three centers, 91 patients completed all study visits and the post study questionnaire with a mean age of 55 and 75% were female and 34% african american. accurate downloads occurred >75% of the time, regardless of age, race, or sex. results of the post-study questionnaire did not show a correlation between the likelihood of wearing the device and motivation to increase activity.
Conclusion: using an activity tracking device to evaluate and/or correlated with quality of life (QOL) instruments may prove beneficial for gathering more data on patients. age, race, and gender did not contribute to differences in usability among sarcoidosis patients.
Details
- Title: Subtitle
- Potential limitations of activity tracking devices in monitoring effects of treatment for sarcoidosis
- Creators
- Rebecca Klein - University of Cincinnati Medical CenterMarc Judson - Albany Medical College. judsonm@amc.eduBriana Barkes - National Jewish HealthLisa Maier - National Jewish HealthJoyce Zeigler - University of Cincinnati Medical CenterDaniel Culver - Cleveland ClinicNadera Sweiss - University of Illinois Urbana-ChampaignEdward Chen - John Hopkins University School of Medicine. chenedwa@jhmi.eduNabeel Hamzeh - National Jewish HealthJan Grutters - St. Antonius Hospital. j.grutters@antoniusziekenhuis.nlDominique Valeyre - Universite Sorbonne Paris Nord. dominique.valeyre@gmail.comNoopur Singh - Xentria. nsingh@meithealpharma.comGinger Spitzer - . spitzerginger@gmail.comTricha Shivas - Foundation for Sarcoidosis Research. tricha@stopsarcoidosis.orgRobert Baughman - University of Cincinnati Medical Center
- Resource Type
- Journal article
- Publication Details
- Sarcoidosis, vasculitis, and diffuse lung diseases, Vol.40(1), e2023010
- DOI
- 10.36141/svdld.v40i1.12395
- PMID
- 36975058
- PMCID
- PMC10099655
- NLM abbreviation
- Sarcoidosis Vasc Diffuse Lung Dis
- ISSN
- 1124-0490
- eISSN
- 2532-179X
- Language
- English
- Date published
- 03/28/2023
- Academic Unit
- Pulmonary, Critical Care, and Occupational Medicine; Internal Medicine
- Record Identifier
- 9984381027002771
Metrics
16 Record Views